PEAPACK GLADSTONE FINANCIAL CORP
Position in BMY — Bristol Myers Squibb Co
CIK 1050743
BEDMINSTER, NJ
Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,312,868
-$1,344,928 QoQ
Shares Held
439,307
-0.1% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#247
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 14%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $425,890,657 across 14 Drug Manufacturers - General names. BMY ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
412,665 | $104,804,529 | |
| 2 | LLY |
ELI LILLY & Co
|
78,019 | $93,578,336 | |
| 3 | MRK |
Merck & Co., Inc.
|
563,132 | $72,362,462 | |
| 4 | ABBV |
AbbVie Inc.
|
209,332 | $52,676,303 | |
| 5 | AMGN |
Amgen Inc
|
87,050 | $31,522,545 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
439,307 | $25,312,868 | |
| 7 | PFE |
Pfizer Inc
|
879,706 | $21,183,319 | |
| 8 | AZN |
Astrazeneca PLC
|
72,990 | $13,840,363 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,312,868 | 439,307 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $26,657,796 | 439,535 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,265,123 | 449,854 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $21,537,820 | 477,557 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $21,226,741 | 458,560 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,231,835 | 479,289 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,407,956 | 484,582 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,509,423 | 493,031 | Shares | Defined | 2024-11-26 | |
| 2024-06-30 | $23,395,592 | 563,342 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $31,387,401 | 578,783 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,893,493 | 602,095 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $36,804,730 | 634,127 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $40,781,553 | 637,710 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $44,882,035 | 647,555 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $46,367,384 | 644,439 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $45,051,295 | 633,722 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $45,908,324 | 596,212 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $42,504,554 | 582,015 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $35,922,140 | 576,137 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $34,036,298 | 575,229 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,220,047 | 542,054 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $34,727,748 | 550,099 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $34,617,948 | 558,084 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $33,437,858 | 554,617 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $33,226,880 | 565,083 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $30,556,444 | 548,196 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||